Jun 10, 2024 · In this study, we have designed a novel peptide-based chimeric vaccine candidate against the N. meningitidis strain 331,401 serogroup X. Through ...
In this study, we have designed a novel peptide-based chimeric vaccine candidate against the N. meningitidis strain 331,401 serogroup X. Through rigorous ...
In this study, we have designed a novel peptide-based chimeric vaccine candidate against the N. meningitidis strain 331,401 serogroup X. Through rigorous ...
Sep 19, 2024 · In this study, we have designed a novel peptide-based chimeric vaccine candidate against the N. meningitidis strain 331,401 serogroup X. Through ...
Feb 8, 2022 · In the current study, we have successfully designed a peptide-based novel antigen chimeric vaccine candidate against the XDR strain of S. typhi H58.
Missing: potential Neisseria meningitides 331401 serogroup X
Neisseria meningitidis serogroup B (NmB) strains have diverse antigens, necessitating methods for predicting meningococcal serogroup B (MenB) vaccine strain ...
Here, we have explored the potential of N. meningitidis lipoprotein NMB0938 as a vaccine candidate, based on investigation of gene sequence conservation and the ...
Numerous studies had widely reported the use of subtractive genomics and reverse vaccinology approaches against various pathogenic strains for the ...
Missing: 331401 X
Based on this assumption, an in silico bioinformatics approach was used to identify novel antigens for vaccine development. The genome was therefore screened ...
Missing: integrated chimeric 331401 subtractive
In the current study, we have successfully designed a peptide-based novel antigen chimeric vaccine candidate against the XDR strain of S. typhi H58.
Missing: Neisseria meningitides 331401 serogroup X